The U.S. Federal Trade Commission (FTC) sued U.S. Anesthesia Partners Inc. (USAP) and an equity firm backing it, alleging the duo engaged in a “multi-year anticompetitive scheme” that drove up prices of anesthesia services in Texas.
In 2012, New York-based private equity firm Welsh, Carson, Anderson & Stowe created USAP, which is now a dominant provider of anesthesia services in Texas.